APOE glycosylation in ADNI CSF data. More information is available at https://adni.loni.usc.edu/data-samples/adni-data/
Usage
data(YASSINE_CSF)
Details
ORIGPROT character , with options: ADNI1, ADNI2
RID numeric Patient ID Range value: 23, ..., 4889
EXAMDATE character Date when the sample is collected
VISCODE2 character Months from baseline rounded to nearest 6 months , with options: bl
Sample_ID character
Number numeric Range value: 1, ..., 25
Type character , with options: CSF
Box numeric Range value: 2, ..., 12
Order_in_Box numeric Range value: 1, ..., 73
MALDI character position of the sample on the MALDI target
Date character , with options: 6/20/2023, 6/21/2023, 6/23/2023
Phenotype character , with options: E4/E4, E3/E4, E3/E3, E2/E3, N/A
E2_level numeric Range value: 0.491, ..., 0.529
E3_level numeric Range value: 0.281, ..., 1
E4_level numeric Range value: 0.609, ..., 1
E3_E2 numeric ratio of E3 and E2 in a sample Range value: 0.891, ..., 1.036
E4_E3 numeric ratio of E4 and E3 in a sample Range value: 1.55, ..., 2.56
E2_glyc numeric Range value: 70, ..., 77.4
E3_glyc numeric Range value: 60.4, ..., 81.2
E4_glyc numeric Range value: 58.6, ..., 79.1
Total_glyc numeric Range value: 58.6, ..., 79.6
E2_2nd_glyc numeric Range value: 19.7, ..., 28.3
E3_2nd_glyc numeric Range value: 13.7, ..., 31.5
E4_2nd_glyc numeric Range value: 10.5, ..., 27.4
Total_2nd_glyc numeric Range value: 10.5, ..., 29.3
update_stamp POSIXct: YYY-MM-DD